North America Enteral Feeding Formulas Market

North America Enteral Feeding Formulas Market Size (2023 to 2028)

As per the research report, the North America Enteral Feeding Devices Market size is valued at USD 1.18 Billion in 2023. This value is estimated to be growing at a CAGR of 7.8% to reach USD 1.72 billion by 2028. A growing number of hospitals and ambulatory care services embrace enteral nutrition as an effective system of clinical nutrition.

The North American Enteral Feeding Devices Market is growing owing to the increase in chronic diseases and disorders, the rapidly increasing geriatric population, the increasing prevalence of preterm births, high healthcare spending, and the high request home care. Enteral feeding is a method of delivering nutrients to the gastrointestinal tract using a tube. It is considered when a person is not safe for oral intake or when oral intake is insufficient to meet nutritional needs. Enteral feeding tubes are available in different types depending on the feeding route, such as a nasal tube, oral tube, and an esophagostomy tube.

The North American Enteral Feeding Devices Market is primarily fuelled by the increasing incidence of chronic diseases and disorders, the rapid growth of the geriatric population, increasing health care spending, the growing prevalence of preterm births, and the ever-increasing demand for Home Care. However, elements such as complications collaborated with enteral nutrition, risks to patient safety, and the occurrence of feeding and medication errors are predicted to restrict the growth of the enteral feeding preparations market to some extent.

Some of the key factors influencing the market's growth include the increasing prevalence of chronic diseases and disorders, the growing geriatric population, increasing the number of premature births, and growing demand for home care. However, complications associated with enteral feeding are hampering the market growth. Between products, the Standard Formulas segment experiences tremendous growth during the forecast period. This segment's growth can be attributed to its heavy use in most enteral-feeding patients, especially those with chronic tube feeding. The North American market is growing at a significant rate due to the increase in the geriatric population and the increasing incidence of chronic diseases and conditions, increasing health care spending, and increased demand for home care in these regions.

Lack of reimbursement for Enteral Feeding Devices is expected to restrict the use of these devices and is expected to slow the market's growth during the forecast period.

This research report on the North American Enteral Feeding Formulas Market has been segmented and sub-segmented into the following categories:

By Product: 

• Polymeric
• Monomeric
• Disease-Specific Formulas

By Stage: 

• Adults
• Pediatrics

By Application: 

• Oncology
• Gastroenterology
• Neurology

By End User: 

• Hospitals
• LTCS
• Home Care

By Country: 

• The United States
• Canada
• Rest of North America

Companies playing a dominant role in the North America Enteral Feeding Formulas Market profiled in this report are Abbott Laboratories (U.S.), Nestlé S.A. (Switzerland), Danone S.A. (France), Fresenius Kabi AG (Germany), Mead Johnson Nutrition Company (U.S.), B. Braun Melsungen AG (Germany), Hormel Foods, LLC (U.S.), Victus Inc. (U.S.), Meiji Holdings Co., Ltd. (Japan), and Global Health Product Inc. (U.S.).